Activation of Rictor/mTORC2 signaling acts as a pivotal strategy to protect against sensorineural hearing loss
Xiaolong Fu(China General Nuclear Power Corporation (China)), Jiangang Gao(Shandong University), Yachun An(Shandong University), Renjie Chai(Medical Protective), Linqing Zhang(Shandong University), Rongyu Yue(Shandong University), Haibo Wang(The Third People's Hospital of Dalian City), Wenwen Liu(Peking University), Peipei Li(Zhengzhou University), Chao Ye(Harbin Veterinary Research Institute), Yuan Zhang(First Affiliated Hospital of Zhengzhou University), Yuning Song(Shandong University), Aizhen Zhang(Shandong University)
Cited by 39
Related Papers
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
|Proceedings of the National Academy of Sciences|2013|644
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324
AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
|The Lancet|2024|323
AAV-ie enables safe and efficient gene transfer to inner ear cells
|Nature Communications|2019|228
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition
|Nature Cell Biology|2024|198